Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 7 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 29, 2026 Filed Oct 2, 2026 00:27 UTC |
Harlow John B. Jr.President and COO
|
GrantStock Option (Right to Buy) · Derivative | 800,000 | $0.00 Strike: $3.14 | $0.00 |
DisclosureSEC source: 0001193125-26-410719 · ownership.xml · derivative · entry 2 Harlow John B. Jr. · CIK 0002095554 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2036-09-29 F2 · derivative.exercise_date: The option vests 25% on September 29, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| September 29, 2026 Filed Oct 2, 2026 00:27 UTC |
Harlow John B. Jr.President and COO
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-410719 · ownership.xml · nonDerivative · entry 1 Harlow John B. Jr. · CIK 0002095554 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 20:05 UTC |
Hamilton Thomas EdwardDirector
|
PurchaseCommon Stock | 50,000 | $3.34 | $166,890.00 |
DisclosureSEC source: 0001193125-26-298523 · ownership.xml · nonDerivative · entry 1 Hamilton Thomas Edward · CIK 0001769848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 714,798 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.33 to $3.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. Read SEC document |
| May 19, 2026 Filed May 21, 2026 00:02 UTC |
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
|
GrantStock Option (Right to Buy) · Derivative | 55,150 | $0.00 Strike: $3.33 | $0.00 |
DisclosureSEC source: 0001193805-26-000669 · e665501_4-larimar.xml · derivative · entry 1 Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Through Deerfield Management Company, L.P. Disclosed balance after: 55,150 Underlying: Common Stock · 55,150 shares Expires 2036-05-19 F1 · shares: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F2 · derivative.exercise_date: The option was granted on May 19, 2026 and is scheduled to vest on the earlier of May 19, 2027 and the date of the Issuer's next annual meeting of stockholders, in each case, subject to Jonathan S. Leff 's continued service on the board of directors of the Issuer. F1 · derivative.underlying_shares: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F1 · balance_after: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F1 · ownership.nature: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F3 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entity listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). James E. Flynn is the sole member of the general partner of Deerfield Management Company, L.P. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:28 UTC |
Truitt JosephDirector
|
GrantStock Option (Right to Buy) · Derivative | 55,150 | $0.00 Strike: $3.33 | $0.00 |
DisclosureSEC source: 0001193125-26-232667 · ownership.xml · derivative · entry 1 Truitt Joseph · CIK 0001452429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,150 Underlying: Common Stock · 55,150 shares Expires 2036-05-19 F1 · derivative.exercise_date: The options vest on the earlier of (a) May 19, 2027 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:24 UTC |
THOMAS FRANK EDirector
|
GrantStock Option (Right to Buy) · Derivative | 55,150 | $0.00 Strike: $3.33 | $0.00 |
DisclosureSEC source: 0001193125-26-232657 · ownership.xml · derivative · entry 1 THOMAS FRANK E · CIK 0001242616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,150 Underlying: Common Stock · 55,150 shares Expires 2036-05-19 F1 · derivative.exercise_date: The options vest on the earlier of (a) May 19, 2027 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company. Read SEC document |
| May 19, 2026 Filed May 20, 2026 22:03 UTC |
LEFF JONATHAN SDirector
|
GrantStock Option (Right to Buy) · Derivative | 55,150 | $0.00 Strike: $3.33 | $0.00 |
DisclosureSEC source: 0001193125-26-232933 · ownership.xml · derivative · entry 1 LEFF JONATHAN S · CIK 0001215242 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,150 Underlying: Common Stock · 55,150 shares Expires 2036-05-19 F1 · shares: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P. F2 · derivative.exercise_date: The options vest on the earlier of (a) May 19, 2027 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company. F1 · derivative.underlying_shares: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P. F1 · balance_after: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:30 UTC |
SHERMAN JEFFREY WDirector
|
GrantStock Option (Right to Buy) · Derivative | 55,150 | $0.00 Strike: $3.33 | $0.00 |
DisclosureSEC source: 0001193125-26-232705 · ownership.xml · derivative · entry 1 SHERMAN JEFFREY W · CIK 0001230482 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,150 Underlying: Common Stock · 55,150 shares Expires 2036-05-19 F1 · derivative.exercise_date: The options vest on the earlier of (a) May 19, 2027 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:21 UTC |
Hamilton Thomas EdwardDirector
|
GrantStock Option (Right to Buy) · Derivative | 55,150 | $0.00 Strike: $3.33 | $0.00 |
DisclosureSEC source: 0001193125-26-232644 · ownership.xml · derivative · entry 1 Hamilton Thomas Edward · CIK 0001769848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,150 Underlying: Common Stock · 55,150 shares Expires 2036-05-19 F1 · derivative.exercise_date: The options vest on the earlier of (a) May 19, 2027 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 00:46 UTC |
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
|
PurchaseCommon Stock | 2,000,000 | $5.00 | $10,000,000.00 |
DisclosureSEC source: 0001193805-26-000205 · e665206_4-larimar.xml · nonDerivative · entry 4 Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Through Deerfield Partners, L.P. Disclosed balance after: 6,207,982 F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 00:46 UTC |
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
|
PurchaseCommon Stock | 831,978 | $5.00 | $4,159,890.00 |
DisclosureSEC source: 0001193805-26-000205 · e665206_4-larimar.xml · nonDerivative · entry 3 Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Through Deerfield Healthcare Innovations Fund, L.P. Disclosed balance after: 8,153,107 F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 00:46 UTC |
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
|
PurchaseCommon Stock | 1,084,012 | $5.00 | $5,420,060.00 |
DisclosureSEC source: 0001193805-26-000205 · e665206_4-larimar.xml · nonDerivative · entry 2 Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Through Deerfield Private Design Fund IV, L.P. Disclosed balance after: 10,622,957 F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 00:46 UTC |
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
|
PurchaseCommon Stock | 1,084,010 | $5.00 | $5,420,050.00 |
DisclosureSEC source: 0001193805-26-000205 · e665206_4-larimar.xml · nonDerivative · entry 1 Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Through Deerfield Private Design Fund III, L.P. Disclosed balance after: 10,622,928 F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 21:30 UTC |
THOMAS FRANK EDirector
|
PurchaseCommon Stock | 5,000 | $5.00 | $25,000.00 |
DisclosureSEC source: 0001193125-26-085514 · ownership.xml · nonDerivative · entry 1 THOMAS FRANK E · CIK 0001242616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,000 F1 · shares: Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on February 27, 2026. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 21:30 UTC |
SHERMAN JEFFREY WDirector
|
PurchaseCommon Stock | 5,000 | $5.00 | $25,000.00 |
DisclosureSEC source: 0001193125-26-085510 · ownership.xml · nonDerivative · entry 1 SHERMAN JEFFREY W · CIK 0001230482 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 F1 · shares: Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on February 27, 2026. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 21:30 UTC |
Hamilton Thomas EdwardDirector
|
PurchaseCommon Stock | 100,000 | $5.00 | $500,000.00 |
DisclosureSEC source: 0001193125-26-085515 · ownership.xml · nonDerivative · entry 1 Hamilton Thomas Edward · CIK 0001769848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 664,798 F1 · shares: Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on February 27, 2026. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 17:03 UTC |
Celano MichaelChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 225,622 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001193125-26-024824 · ownership.xml · derivative · entry 2 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,622 Underlying: Common Stock · 225,622 shares Expires 2036-01-26 F2 · derivative.exercise_date: The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 17:03 UTC |
Celano MichaelChief Financial Officer
|
GrantCommon Stock | 37,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-024824 · ownership.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,785 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 22:04 UTC |
Shankar GopiChief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 153,822 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001193125-26-024833 · ownership.xml · derivative · entry 2 Shankar Gopi · CIK 0001965014 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,822 Underlying: Common Stock · 153,822 shares Expires 2036-01-26 F2 · derivative.exercise_date: The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 22:04 UTC |
Shankar GopiChief Development Officer
|
GrantCommon Stock | 25,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-024833 · ownership.xml · nonDerivative · entry 1 Shankar Gopi · CIK 0001965014 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,443 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 22:04 UTC |
Clayton RussellChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 153,822 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001193125-26-024832 · ownership.xml · derivative · entry 2 Clayton Russell · CIK 0001530072 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,822 Underlying: Common Stock · 153,822 shares Expires 2036-01-26 F2 · derivative.exercise_date: The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 22:04 UTC |
Clayton RussellChief Medical Officer
|
GrantCommon Stock | 25,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-024832 · ownership.xml · nonDerivative · entry 1 Clayton Russell · CIK 0001530072 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,443 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 22:04 UTC |
BEN-MAIMON CAROLEDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 600,600 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001193125-26-024826 · ownership.xml · derivative · entry 7 BEN-MAIMON CAROLE · CIK 0001529611 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,600 Underlying: Common Stock · 600,600 shares Expires 2036-01-26 F7 · derivative.exercise_date: The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 22:04 UTC |
BEN-MAIMON CAROLEDirector · President and CEO
|
GrantCommon Stock | 100,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-024826 · ownership.xml · nonDerivative · entry 1 BEN-MAIMON CAROLE · CIK 0001529611 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,276 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 22:28 UTC |
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
|
PurchaseCommon Stock | 2,599,932 | $3.20 | $8,319,782.40 |
DisclosureSEC source: 0001193805-25-001155 · e664762_4-larimar.xml · nonDerivative · entry 3 Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Through Deerfield Healthcare Innovations Fund, L.P. Disclosed balance after: 7,321,129 F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 22:28 UTC |
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
|
PurchaseCommon Stock | 3,387,539 | $3.20 | $10,840,124.80 |
DisclosureSEC source: 0001193805-25-001155 · e664762_4-larimar.xml · nonDerivative · entry 2 Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Through Deerfield Private Design Fund IV, L.P. Disclosed balance after: 9,538,945 F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 22:28 UTC |
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
|
PurchaseCommon Stock | 3,387,529 | $3.20 | $10,840,092.80 |
DisclosureSEC source: 0001193805-25-001155 · e664762_4-larimar.xml · nonDerivative · entry 1 Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization DEERFIELD MANAGEMENT COMPANY, L.P. · CIK 0001009258 · Director · 10% owner · * Director by Deputization Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Through Deerfield Private Design Fund III, L.P. Disclosed balance after: 9,538,918 F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| May 13, 2025 Filed May 14, 2025 20:33 UTC |
Truitt JosephDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001062993-25-009379 · form4.xml · derivative · entry 1 Truitt Joseph · CIK 0001452429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires 2035-05-13 F1 · derivative.exercise_date: The options vest on the earlier of (a) May 13, 2026 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company. Read SEC document |
| May 13, 2025 Filed May 14, 2025 20:32 UTC |
THOMAS FRANK EDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001062993-25-009377 · form4.xml · derivative · entry 1 THOMAS FRANK E · CIK 0001242616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires 2035-05-13 F1 · derivative.exercise_date: The options vest on the earlier of (a) May 13, 2026 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company. Read SEC document |
| May 13, 2025 Filed May 14, 2025 20:32 UTC |
LEFF JONATHAN SDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001062993-25-009376 · form4.xml · derivative · entry 1 LEFF JONATHAN S · CIK 0001215242 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires 2035-05-13 F1 · shares: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P. F2 · derivative.exercise_date: The options vest on the earlier of (a) May 13, 2026 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company. F1 · derivative.underlying_shares: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P. F1 · balance_after: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P. Read SEC document |
| May 13, 2025 Filed May 14, 2025 20:34 UTC |
SHERMAN JEFFREY WDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001062993-25-009380 · form4.xml · derivative · entry 1 SHERMAN JEFFREY W · CIK 0001230482 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires 2035-05-13 F1 · derivative.exercise_date: The options vest on the earlier of (a) May 13, 2026 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company. Read SEC document |
| May 13, 2025 Filed May 14, 2025 20:33 UTC |
Hamilton Thomas EdwardDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001062993-25-009378 · form4.xml · derivative · entry 1 Hamilton Thomas Edward · CIK 0001769848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires 2035-05-13 F1 · derivative.exercise_date: The options vest on the earlier of (a) May 13, 2026 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company. Read SEC document |
| May 13, 2025 Filed May 15, 2025 23:44 UTC |
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
|
GrantStock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001193805-25-000672 · e664519_4-larimar.xml · derivative · entry 1 Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · Director · 10% owner · * Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Through Deerfield Management Company, L.P. Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires 2035-05-13 F1 · shares: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F2 · derivative.exercise_date: The option was granted on May 13, 2025 and is scheduled to vest on the earlier of May 13, 2026 and the date of the Issuer's next annual meeting of stockholders, in each case, subject to Jonathan S. Leff 's continued service on the board of directors of the Issuer. F1 · derivative.underlying_shares: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F1 · balance_after: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F1 · ownership.nature: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F3 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entity listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). James E. Flynn is the sole member of the general partner of Deerfield Management Company, L.P. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 16:15 UTC |
Celano MichaelChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 205,111 | $0.00 Strike: $3.46 | $0.00 |
DisclosureSEC source: 0001062993-25-001077 · form4.xml · derivative · entry 2 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,111 Underlying: Common Stock · 205,111 shares Expires 2035-01-22 F2 · derivative.exercise_date: The option vests 25% on January 22, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 16:15 UTC |
Celano MichaelChief Financial Officer
|
GrantCommon Stock | 34,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-001077 · form4.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,181 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 21:16 UTC |
Shankar GopiChief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 139,838 | $0.00 Strike: $3.46 | $0.00 |
DisclosureSEC source: 0001062993-25-001080 · form4.xml · derivative · entry 2 Shankar Gopi · CIK 0001965014 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,838 Underlying: Common Stock · 139,838 shares Expires 2035-01-22 F2 · derivative.exercise_date: The option vests 25% on January 22, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 21:16 UTC |
Shankar GopiChief Development Officer
|
GrantCommon Stock | 23,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-001080 · form4.xml · nonDerivative · entry 1 Shankar Gopi · CIK 0001965014 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,806 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 21:16 UTC |
Clayton RussellChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 139,838 | $0.00 Strike: $3.46 | $0.00 |
DisclosureSEC source: 0001062993-25-001079 · form4.xml · derivative · entry 2 Clayton Russell · CIK 0001530072 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,838 Underlying: Common Stock · 139,838 shares Expires 2035-01-22 F2 · derivative.exercise_date: The option vests 25% on January 22, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 21:16 UTC |
Clayton RussellChief Medical Officer
|
GrantCommon Stock | 23,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-001079 · form4.xml · nonDerivative · entry 1 Clayton Russell · CIK 0001530072 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,806 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 21:15 UTC |
BEN-MAIMON CAROLEDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 546,000 | $0.00 Strike: $3.46 | $0.00 |
DisclosureSEC source: 0001062993-25-001078 · form4.xml · derivative · entry 5 BEN-MAIMON CAROLE · CIK 0001529611 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 546,000 Underlying: Common Stock · 546,000 shares Expires 2035-01-22 F5 · derivative.exercise_date: The option vests 25% on January 22, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 21:15 UTC |
BEN-MAIMON CAROLEDirector · President and CEO
|
GrantCommon Stock | 91,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-001078 · form4.xml · nonDerivative · entry 1 BEN-MAIMON CAROLE · CIK 0001529611 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 387,208 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:57 UTC |
Truitt JosephDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $7.07 | $0.00 |
DisclosureSEC source: 0001062993-24-011569 · form4.xml · derivative · entry 1 Truitt Joseph · CIK 0001452429 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires 2034-05-29 F1 · derivative.exercise_date: The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:58 UTC |
THOMAS FRANK EDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $7.07 | $0.00 |
DisclosureSEC source: 0001062993-24-011572 · form4.xml · derivative · entry 1 THOMAS FRANK E · CIK 0001242616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires 2034-05-29 F1 · derivative.exercise_date: The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:57 UTC |
LEFF JONATHAN SDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $7.07 | $0.00 |
DisclosureSEC source: 0001062993-24-011571 · form4.xml · derivative · entry 1 LEFF JONATHAN S · CIK 0001215242 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires 2034-05-29 F1 · shares: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P. F2 · derivative.exercise_date: The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company. F1 · derivative.underlying_shares: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P. F1 · balance_after: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the options for the benefit, and at the direction, of Deerfield Management Company, L.P. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:57 UTC |
SHERMAN JEFFREY WDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $7.07 | $0.00 |
DisclosureSEC source: 0001062993-24-011570 · form4.xml · derivative · entry 1 SHERMAN JEFFREY W · CIK 0001230482 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires 2034-05-29 F1 · derivative.exercise_date: The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:56 UTC |
Hamilton Thomas EdwardDirector
|
GrantStock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $7.07 | $0.00 |
DisclosureSEC source: 0001062993-24-011568 · form4.xml · derivative · entry 3 Hamilton Thomas Edward · CIK 0001769848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires 2034-05-29 F2 · derivative.exercise_date: The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company. Read SEC document |
| May 29, 2024 Filed Jun 3, 2024 22:31 UTC |
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
|
GrantStock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $7.07 | $0.00 |
DisclosureSEC source: 0001193805-24-000743 · e663682_4-larimar.xml · derivative · entry 1 Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · Director · 10% owner · * Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Through Deerfield Management Company, L.P. Disclosed balance after: 19,000 Underlying: Common Stock · 19,000 shares Expires 2034-05-29 F1 · shares: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F2 · derivative.exercise_date: The option was granted on May 29, 2024 and is scheduled to vest on the earlier of May 29, 2025 and the date of the Issuer's next annual meeting of stockholders, in each case, subject to Jonathan S. Leff 's continued service on the board of directors of the Issuer. F1 · derivative.underlying_shares: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F1 · balance_after: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F1 · ownership.nature: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F3 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entity listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). James E. Flynn is the sole member of the general partner of Deerfield Management Company, L.P. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| February 16, 2024 Filed Feb 16, 2024 19:37 UTC |
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
|
PurchaseCommon Stock | 1,430,205 | $8.74 | $12,499,991.70 |
DisclosureSEC source: 0001193805-24-000245 · e619284_4-larimar.xml · nonDerivative · entry 3 Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · Director · 10% owner · * Director by Deputization Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Through Deerfield Partners, L.P. Disclosed balance after: 4,207,982 F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| February 16, 2024 Filed Feb 16, 2024 19:37 UTC |
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
|
PurchaseCommon Stock | 1,430,206 | $8.74 | $12,500,000.44 |
DisclosureSEC source: 0001193805-24-000245 · e619284_4-larimar.xml · nonDerivative · entry 2 Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · Director · 10% owner · * Director by Deputization Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Through Deerfield Private Design Fund IV, L.P. Disclosed balance after: 6,151,406 F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| February 16, 2024 Filed Feb 16, 2024 19:37 UTC |
Flynn James EDirector · 10% owner · * Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt HIF, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt IV, L.P.Director · 10% owner · * Director by Deputization
Deerfield Mgmt L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund III, L.P.Director · 10% owner · * Director by Deputization
Deerfield Healthcare Innovations Fund, L.P.Director · 10% owner · * Director by Deputization
Deerfield Private Design Fund IV, L.P.Director · 10% owner · * Director by Deputization
DEERFIELD PARTNERS, L.P.Director · 10% owner · * Director by Deputization
|
PurchaseCommon Stock | 1,430,206 | $8.74 | $12,500,000.44 |
DisclosureSEC source: 0001193805-24-000245 · e619284_4-larimar.xml · nonDerivative · entry 1 Flynn James E · CIK 0001352546 · Director · 10% owner · * Director by Deputization DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · Director · 10% owner · * Director by Deputization Deerfield Mgmt III, L.P. · CIK 0001610540 · Director · 10% owner · * Director by Deputization Deerfield Mgmt HIF, L.P. · CIK 0001665736 · Director · 10% owner · * Director by Deputization Deerfield Mgmt IV, L.P. · CIK 0001713467 · Director · 10% owner · * Director by Deputization Deerfield Mgmt L.P. · CIK 0001010823 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund III, L.P. · CIK 0001603333 · Director · 10% owner · * Director by Deputization Deerfield Healthcare Innovations Fund, L.P. · CIK 0001646981 · Director · 10% owner · * Director by Deputization Deerfield Private Design Fund IV, L.P. · CIK 0001680307 · Director · 10% owner · * Director by Deputization DEERFIELD PARTNERS, L.P. · CIK 0001301041 · Director · 10% owner · * Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Through Deerfield Private Design Fund III, L.P. Disclosed balance after: 6,151,389 F1 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. ("Deerfield HIF"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the "Funds"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. F2 · ownership.nature: In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.